A Study Assessing Adult Patients Referred to an NHS Sleep Service With Suspected Obstructive Sleep Apnoea. This Study Aims to Compare the Sunrise Wearable Diagnostic Device Performance and Potential Inclusion in a NHS Diagnostic Pathway With Oximetry and WatchPAT Which Are Currently Used.
Recruiting
N/A
Interventional Study
Obstructive Sleep Apnoea (OSA)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Virginia Hawkins · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate whether the Sunrise device (that measure small jaw movements) can improve the diagnosis and management of Obstructive Sleep Apnoea (OSA) in adults (≥ 18 years) referred to a Sleep Clinic.
The main question it aims to answer are:
\- Does Sunrise lead to a higher proportion of definitive management decisions (initiate OSA treatment, discharge from the…
Trial Locations
Sorted by distance from Connecticut
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* • Adults (aged ≥18 years old) referred with suspected Obstructive Sleep Apnoea
* Patient has capacity to provide informed consent
* Patient has access to a smartphone with Bluetooth and WiFi or internet data to download the Sunrise app and to transmit the Sunrise results …
Contacts